News
Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States ...
Apellis Pharma (APLS) stock in focus as the FDA expands the label for its injectable therapy Empaveli to treat rare kidney ...
DURECT's lead asset, Larsucosterol, is an epigenetic modulator with FDA Breakthrough Therapy Designation Potential to be the first FDA-approved therapeutic option for the treatment of ...
The FDA granted 510(k) clearance to two devices, HyHub and HyHub Duo, that act as docking stations for dual vial units to ...
Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...
2d
Medical Device Network on MSNStereotaxis wins FDA clearance for diagnostic mapping catheterMAGiC Sweep is claimed to be the first robotically navigated electrophysiology mapping catheter approved by the FDA.
The clinical-stage biopharmaceutical company said its ateganosine treatment is being evaluated in a phase two clinical trial. If relevant criteria is met during the FDA fast track process, then the ...
Stereotaxis shares were higher after the company said it has received Food and Drug Administration clearance for its robotically navigated high-density electrophysiology mapping catheter. Shares were ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
From softwares to implants, here are 10 spine products earning FDA nods since May 15. 1. Accelus’ FlareHawk interbody fusion device was FDA-cleared for use in MRI scanning under certain conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results